ID   NT2.5 BO3
AC   CVCL_JA61
SY   BO3; Bo3
DR   GEO; GSM1155325
DR   Wikidata; Q54931106
RX   PubMed=19642106;
CC   Characteristics: Produced by injection of NT2.5 cells into the left cardiac ventricle of neu-N mice resulting in the formation of metastatic lesions in bone. These metastatic lesions were established in cell culture and subsequently reinjected into neu-N mice. This selection process was repeated until sublines with a bone preference were obtained.
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA60 ! NT2.5
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 5
//
RX   PubMed=19642106; DOI=10.1002/ijc.24780;
RA   Lau W.M., Weber K.L., Doucet M., Chou Y.-T., Brady K., Kowalski J.,
RA   Tsai H.-L., Yang J., Kominsky S.L.;
RT   "Identification of prospective factors promoting osteotropism in
RT   breast cancer: a potential role for CITED2.";
RL   Int. J. Cancer 126:876-884(2010).
//